Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)
Conditions: Overactive Bladder; Benign Prostatic HyperplasiaIntervention: Drug: doxazosin plus tolterodine SRSponsors: Samsung Medical Center; Samsung Medical CenterRecruiting - verified June 2013
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Benign Prostatic Hyperplasia | Doxazosin | Overactive Bladder | Overactive Bladder Syndrome | Research